| A genome editing approach to study cancer stem cells in human tumors C Cortina, G Turon, D Stork, X Hernando‐Momblona, M Sevillano, ... EMBO molecular medicine 9 (7), 869-879, 2017 | 116 | 2017 |
| Autogenous control of 5′ TOP mRNA stability by 40S ribosomes A Gentilella, FD Moron-Duran, P Fuentes, G Zweig-Rocha, ... Molecular cell 67 (1), 55-70. e4, 2017 | 101 | 2017 |
| Zonation of ribosomal DNA transcription defines a stem cell hierarchy in colorectal cancer C Morral, J Stanisavljevic, X Hernando-Momblona, E Mereu, ... Cell Stem Cell 26 (6), 845-861. e12, 2020 | 67 | 2020 |
| Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells A Cañellas-Socias, C Cortina, X Hernando-Momblona, S Palomo-Ponce, ... Nature 611 (7936), 603-613, 2022 | 63 | 2022 |
| Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy A Alvarez-Varela, L Novellasdemunt, FM Barriga, X Hernando-Momblona, ... Nature Cancer 3 (9), 1052-1070, 2022 | 46 | 2022 |
| First fully-automated AI/ML virtual screening cascade implemented at a drug discovery centre in Africa G Turon, J Hlozek, JG Woodland, A Kumar, K Chibale, M Duran-Frigola Nature Communications 14 (1), 5736, 2023 | 13 | 2023 |
| Bioactivity profile similarities to expand the repertoire of COVID-19 drugs M Duran-Frigola, M Bertoni, R Blanco, V Martínez, E Pauls, V Alcalde, ... Journal of Chemical Information and Modeling 60 (12), 5730-5734, 2020 | 5 | 2020 |
| Artificial intelligence for antiviral drug discovery in low resourced settings: A perspective CT Namba-Nzanguim, G Turon, CV Simoben, I Tietjen, LJ Montaner, ... Frontiers in Drug Discovery 2, 1013285, 2022 | 4 | 2022 |
| A genome editing approach to study cancer stem cells in human tumors. EMBO Mol Med. 2017; 9 (7): 869–79 C Cortina, G Turon, D Stork, X Hernando-Momblona, M Sevillano, ... | 2 | |
| AI can help to tailor drugs for Africa—but Africans should lead the way G Turon, M Njoroge, M Mulubwa, M Duran-Frigola, K Chibale Nature 628 (8007), 265-267, 2024 | | 2024 |
| Machine learning approaches identify chemical features for stage-specific antimalarial compounds A Van Heerden, G Turon, M Duran-Frigola, N Pillay, LM Birkholtz ACS omega 8 (46), 43813-43826, 2023 | | 2023 |
| Unleashing Data Science in Africa for Infectious Disease Research: Hands-On Workshop on AI/ML Tools G Turon Open Infrastructure Fund/Fondo de Infraestructura Abierta, 2023 | | 2023 |
| Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells E Batlle, A Caņellas Socias, C Cortina, X Hernando Momblona, ... Nature, 2022, vol. 611, p. 603–613, 2022 | | 2022 |
| A genome editing based approach to study tumor cell heterogeneity G Turon Universitat de Barcelona, 2019 | | 2019 |
| ENABLE 2017, the First European PhD and Post-Doc Symposium. Session 2: The OMICS Revolution G Di Mauro, A Dondi, G Giangreco, A Hogrebe, E Louer, E Magistrati, ... Biomolecules 8 (4), 116, 2018 | | 2018 |
| ENABLE 2017, the First European PhD and Post-Doc Symposium. Session 1: Building the Foundations of Biology: Synthetic and Cellular Research G Di Mauro, A Dondi, G Giangreco, A Hogrebe, E Louer, E Magistrati, ... Biomolecules 8 (3), 46, 2018 | | 2018 |
| ENABLE 2017, the First EUROPEAN PhD and Post-Doc Symposium. Session 4: From Discovery to Cure: The Future of Therapeutics G Di Mauro, A Dondi, G Giangreco, A Hogrebe, E Louer, E Magistrati, ... Medical Sciences 6 (2), 42, 2018 | | 2018 |
| ENABLE 2017, the First EUROPEAN PhD and Post-Doc Symposium. Session 3: In Vitro to In Vivo: Modeling Life in 3D G Di Mauro, A Dondi, G Giangreco, A Hogrebe, E Louer, E Magistrati, ... Journal of Personalized Medicine 8 (2), 20, 2018 | | 2018 |
| OP06: Ersilia, a Hub of Open-Source AI/ML Models for Drug Discovery and Global Health G Turon, M Duran-Frigola Book of Abstracts, 22, 0 | | |
